Discover a GLP-1 RA for Your Adult Patients With T2D and ASCVD sponsored by Novo Nordisk

Friday, May 13, 2022

12:15 PM – 1:15 PM

Location: Learning Lab A - AACE Learning Zone

Presenter(s)

Helen L. Baron, MD
Endocrinology and Diabetes Medical Director, Diabetes Education Services
Eisenhower Medical Center
Rancho Mirage, California, United States

Disclosure: Disclosure information not submitted.

Discuss ASCVD and how it relates to patients with T2D. Review guideline recommendations for patients with T2D and established ASCVD. Evaluate the efficacy and safety of once-weekly GLP-1 RA clinical trials including a cardiovascular outcomes trial, and glycemic control trials, including a dose comparison. Explore updated dosing and administration for a GLP-1 RA.

Participants should be aware of the following financial/non-financial relationships:

Helen L. Baron, MD: Disclosure information not submitted.